Sonnet BioTherapeutics (SONN) announced that the United States Patent and Trademark Office has issued a Notice of Allowance to the Company for ...
Unique approach targets IL-18 with a smaller, IL-18 fusion protein antagonist, with potential for more effective distribution to inflamed tissues than traditional monoclonal antibodies EVO301 has ...
Hosted on MSN4mon
TRAFFIC ALERT: Part of IL-18 shut down after deadly crashAccording to the ISP, the two-vehicle crash occurred on Illinois Route 18 near County Road 1600 E and included a truck-tractor semi-trailer. ISP has closed roads between IL-89 in Magnolia to E. 1 ...
PALO ALTO, CA, USA I March 17, 2025 I Evommune, Inc., a clinical stage biotechnology company discovering and developing new ways to treat immune-mediated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results